Production (Stage)
Precigen, Inc.
PGEN
$1.33
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.32M | 1.18M | 952.00K | 704.00K | 1.06M |
| Total Other Revenue | 23.00K | 11.00K | 1.00K | 13.00K | 8.00K |
| Total Revenue | 1.34M | 1.19M | 953.00K | 717.00K | 1.07M |
| Cost of Revenue | 1.10M | 54.24M | 1.01M | 16.71M | 1.08M |
| Gross Profit | 241.00K | -53.05M | -56.00K | -15.99M | -10.00K |
| SG&A Expenses | 12.36M | 11.00M | 9.84M | 10.31M | 10.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.94M | 23.93M | 22.22M | 27.01M | 25.48M |
| Operating Income | -22.60M | -22.74M | -21.26M | -26.30M | -24.41M |
| Income Before Tax | -54.15M | -19.81M | -23.97M | -60.48M | -23.77M |
| Income Tax Expenses | -- | -87.00K | 12.00K | -1.69M | -29.00K |
| Earnings from Continuing Operations | -54.15M | -19.73M | -23.98M | -58.79M | -23.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -54.15M | -19.73M | -23.98M | -58.79M | -23.74M |
| EBIT | -22.60M | -22.74M | -21.26M | -26.30M | -24.41M |
| EBITDA | -21.97M | -22.08M | -20.59M | -24.70M | -22.82M |
| EPS Basic | -0.18 | -0.07 | -0.09 | -0.23 | -0.10 |
| Normalized Basic EPS | -0.12 | -0.05 | -0.05 | -0.06 | -0.06 |
| EPS Diluted | -0.18 | -0.07 | -0.09 | -0.23 | -0.10 |
| Normalized Diluted EPS | -0.12 | -0.05 | -0.05 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 293.88M | 293.15M | 275.88M | 252.37M | 249.22M |
| Average Diluted Shares Outstanding | 293.88M | 293.15M | 275.88M | 252.37M | 249.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |